Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review

Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review

The SARS-CoV-2 outbreak originally appeared in China in December 2019 and became a global pandemic in March 2020. This infectious disease has directly affected public health and the world economy. Several palliative therapeutic treatments and prophylaxis strategies have been used to control the prog...

Full description

Bibliographic Details
Main Authors: Bruno Silva Andrade, Fernanda de Souza Rangel, Naiane Oliveira Santos, Andria dos Santos Freitas, Wagner Rodrigues de Assis Soares, Sérgio Siqueira, Debmalya Barh, Aristóteles Góes-Neto, Alexander Birbrair, Vasco Ariston de Carvalho Azevedo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Pharmacology
Subjects:
SARS-CoV-2
prophylaxis
antiviral
drug repurposing
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.590598/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.590598/full

Similar Items